Stock Market Watch

DaVita Inc. – Earnings worse than the estimates

by ·




DaVita Inc. (NYSE:DVA). Last Market Price: 73.04, Change: -0.48, % Change: (-0.65%). Shares trade in the range of 70.77 – 74.94 dollars. It has a market capitalization of 6.82B dollars, making it a Mid Cap Stock and has 93.40M outstanding shares. The company has a beta of 0.42, indicating, the stock to be less volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is 3.83; P/E of 19.07 indicating, the stock to be overvalued or expected increase in company earnings. It operates in Healthcare sector and belongs to Healthcare Facilities industry. Percentage shares held by institutional investors is 98%. The company has a 52 week Price range (low – high) of $ 59.14 – 89.76. Average volumes of shares traded daily are 1,620,000. Volume traded in the last session was at 581,288, 0.36 times the average volume.

  • Reports Q3 (Sep)
    • EPS of $1.45, worse than the estimates
    • Revenues rose 9.6% year on year to $1.81 billion
  • States: Our operating income guidance for 2011 is still expected to be in the range of $1,125 million to $1,155 million. We are raising our operating cash flow guidance for 2011 to now be in the range of $1,020 million to $1,100 million. We are also confirming our operating income guidance range for 2012 of $1,200 million to $1,300 million, as previously provided.

For Q2 (Jun ’11), It had a Net profit margin of 7.05%, an Operating margin of 14.43%. Other Key stats and ratios are : Return on average assets of 5.86%, Return on average equity of 20.30%. The organization has an employee strength of 36,500

Consensus Recommendation is a Outperform.


Estimate for sales for the Quarter Ending Dec-11 show a mean of 1,833.49 million dollars, an estimate high of 1,891.42 million dollars and an estimate low of 1,752.00 million dollars. A year ago the figures stood at 1,692.49 million dollars.

Estimate for sales for the Quarter Ending Mar-12 show a mean of 1,835.12 million dollars, an estimate high of 1,863.39 million dollars and an estimate low of 1,787.23 million dollars. A year ago the figures stood at 1,730.42 million dollars.

Estimate for EPS for the Quarter Ending Dec-11 show a mean of 1.46 dollars, an estimate high of 1.53 dollars and an estimate low of 1.33 dollars. A year ago the figures stood at 1.21 dollars.

Estimate for EPS for the Quarter Ending Mar-12 show a mean of 1.44 dollars, an estimate high of 1.53 dollars and an estimate low of 1.30 dollars. A year ago the figures stood at 1.32 dollars.

Sales for Quarter Ending Sep-11 was estimated at 1,781.72 million dollars, however the actual sales figure stood at 1,807.87 million dollars, 26.15 million dollars more than estimates.

Sales for Quarter Ending Jun-11 was estimated at 1,668.42 million dollars, however the actual sales figure stood at 1,711.53 million dollars, 43.11 million dollars more than estimates.

edliston
Post Written By: Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.


Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...